65,437 trials
Placebo · Expectations
Primary: Behavioral: Within Participant Subjective Outcome Ratings of Acute Thermal Pain Following High Compared to Low Cues — 8.20 units on a scale — p=< .001
Diabetes Mellitus, Type 2
Primary: GFR (Glomerular Filtration Rate) Change After Treatment — 22; 1; 8; 0 ml/min/1.73m^2
Metabolic Syndrome
Primary: L5 Concentration in Metabolic Syndrome Patients — 35.97; 17.8233; 29.736; 23.1 mg/dL
Benign Prostatic Hyperplasia (BPH)
Primary: The Primary Objective is to Evaluate the Safety of Prostate Artery Embolization (PAE) for the Treatment of Lower Urinary Tract Symptoms (LUTS) Attributed to Benign…
Advanced Solid Tumors
Primary: Dose Verification and PK Sub-study: Number Participants With Adverse Events — 20; 54; 9; 21 Participants
Breast Cancer
Primary: Local Recurrence — 3.1 percentage of participants
Social Emotional Wellness
Primary: Change in Social Emotional Competence — 25.33; 20.00 units on a scale
Chronic Insomnia
Primary: Insomnia Severity Index — 7.03; 9.26 score on a scale
Psoriatic Arthritis
Primary: Percentage of Participants Able to Self-administer Safe and Effective Injections Using the Bimekizumab Safety Syringe (BKZ-SS) or the Bimekizumab Auto-injector (BKZ-AI)…
Recurrent Glioblastoma
Primary: Median Overall Survival (OS) — 7.5; 12 months
Hypertension · Renal Failure Chronic Requiring Hemodialysis · Blood Pressure
Primary: Number of Participants Assessed for Intensive (110-140 mm Hg) and Standard (155-165mm Hg) Pre-dialysis Standardized BP Goal — 62; 64 participants
Brain Neoplasms
Primary: Establish a Safe Dose for Oral 5-ALA Administration — 0; 0; 0; 0 Dose Limiting Toxicity
Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies
Primary: Response Rate of Patients Receiving Crenolanib Therapy — 8; 3; 4; 1 Participants
Cataract
Primary: Best Corrected Visual Acuity (BCVA) (Pre-op) — .28 LogMar
Chronic Liver Disease · Advanced Fibrosis · Advanced Cirrhosis
Primary: Median Endoscopic Ultrasound (EUS) Shear Wave Elastography — 0.11 kPA